Extracellular matrix abnormalities in schizophrenia.

Area of Science:

• Neuroscience
• Cell Biology
• Psychiatry

Background:

• The brain's extracellular matrix (ECM) plays a role in schizophrenia (SZ).
• Abnormalities in ECM components like Reelin and chondroitin sulfate proteoglycans (CSPGs) are observed in SZ.
• Reelin is crucial for corticogenesis and synaptic function, while CSPGs regulate neuronal development and synaptic plasticity.

Purpose of the Study:

• To investigate the role of ECM abnormalities in the pathophysiology of schizophrenia.
• To examine the specific changes in CSPGs and Reelin in the brains of individuals with schizophrenia.

Main Methods:

• Analysis of ECM components in post-mortem brain tissue from individuals with schizophrenia and bipolar disorder.
• Immunohistochemical staining to assess glial cells expressing CSPGs and perineuronal nets.
• Evaluation of Reelin expression in relation to GABAergic neurons.

Main Results:

• Significant abnormalities in CSPGs were found in the amygdala and entorhinal cortex of schizophrenia patients, but not bipolar disorder patients.
• Increased glial cells expressing CSPGs and reduced perineuronal nets were observed in schizophrenia.
• Reelin expression changes were noted, often linked to GABAergic abnormalities.

Conclusions:

• The brain's extracellular matrix is a key factor in schizophrenia pathophysiology.
• ECM abnormalities, particularly involving CSPGs and Reelin, may contribute to disrupted connectivity, neuronal migration, and altered neurotransmission in schizophrenia.
• These findings highlight the ECM as a potential therapeutic target for schizophrenia.